Company
Headquarters: Paris, France
Employees: 47
CEO: Mr. Michel Finance
€58.8 Million
EUR as of Jan. 1, 2025
US$61.1 Million
Company | Market Cap (USD) |
---|---|
Abbott | $213.72 B |
Stryker | $150.01 B |
Boston Scientific Corporation | $149.80 B |
Medtronic | $114.44 B |
Shenzhen Mindray Bio-Medical Electronics Co. Ltd | $47.37 B |
Company | Market Cap (USD) |
---|---|
Lilly | $689.42 B |
Novo Nordisk | $622.07 B |
UnitedHealth Group | $487.54 B |
Johnson & Johnson | $353.05 B |
AbbVie | $301.60 B |
Affluent Medical SA, a medical devices company, designs, develops, manufactures, and markets implantable prostheses devices in France. The company develops Kardiozis prosthesis for the noninvasive treatment of abdominal aortic aneurysm; Kalios and Epygon implants for the treatment of mitral insufficiency; and Artus implant, an artificial electromechanical implantable sphincter for severe urinary incontinence in women and men. The company was founded in 2011 and is headquartered in Aix-en-Provence, France.
Top 1-year algo backtest: +327.04%
$10,000 in March 2024 would now be $42,704 by following this algorithm daily at market close.
Use AI to boost your investing & swing trading, now!
Try Disfold DeepFinance FREE
Affluent Medical SA has the following listings and related stock indices.
Stock: Euronext: AFME wb_incandescent
Stock: FSX: 0JZ wb_incandescent